These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38960363)

  • 1. KAT7 Suppresses Tumorigenesis in Clear Cell Renal Cell Carcinoma (ccRCC) by Regulating Cell Cycle and Ferroptosis Sensitivity.
    Hong G; Chen W; Gong M; Wu Y; Shu G; Xiao Y; Zhang T; ShuXiong X
    Exp Cell Res; 2024 Jul; ():114149. PubMed ID: 38960363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RP11-367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial-mesenchymal transition.
    Shao IH; Peng PH; Wu HH; Chen JL; Lai JC; Chang JS; Wu HT; Wu KJ; Pang ST; Hsu KW
    Cancer Med; 2023 Apr; 12(8):9788-9801. PubMed ID: 36847128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of homeobox D10 expression suppresses invasion and migration of clear cell renal cell carcinoma through targeting of E-cadherin.
    Ren Z; Niu Y; Fan B; Zhang A
    Mol Biol Rep; 2022 Mar; 49(3):1837-1846. PubMed ID: 34825321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formin-related protein 1 facilitates proliferation and aggressive phenotype of clear cell renal cell carcinoma through MAPK/MMP2 pathway.
    Ma G; Zhang B; Fu S; Lu J; Zhang L; Shang P; Yue Z
    Mol Cell Probes; 2023 Oct; 71():101921. PubMed ID: 37454877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of GDF15 suppresses ferroptosis and predicts unfavorable prognosis in clear cell renal cell carcinoma.
    Yang D; He Z; Lu J; Yuan X; Liu H; Xue Y; Chen T; Gu H
    Cell Div; 2023 Dec; 18(1):21. PubMed ID: 38082448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF18 Inhibits Clear Cell Renal Cell Carcinoma Proliferation and Invasion via Regulating Epithelial-Mesenchymal Transition.
    Yang C; Zhang Z; Ye F; Mou Z; Chen X; Ou Y; Xu C; Wu S; Cheng Z; Hu J; Zou L; Jiang H
    Front Oncol; 2020; 10():1685. PubMed ID: 33117668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma.
    Lu Y; Qin H; Jiang B; Lu W; Hao J; Cao W; Du L; Chen W; Zhao X; Guo H
    Cancer Lett; 2021 Dec; 522():1-13. PubMed ID: 34520818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEIS1 inhibits clear cell renal cell carcinoma cells proliferation and in vitro invasion or migration.
    Zhu J; Cui L; Xu A; Yin X; Li F; Gao J
    BMC Cancer; 2017 Mar; 17(1):176. PubMed ID: 28270206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CX3CL1 promotes cell sensitivity to ferroptosis and is associated with the tumor microenvironment in clear cell renal cell carcinoma.
    Gong Q; Guo Z; Sun W; Du X; Jiang Y; Liu F
    BMC Cancer; 2022 Nov; 22(1):1184. PubMed ID: 36397015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KAT7 promoted gastric cancer progression through promoting YAP1 activation.
    Guo X; Li Y; Wan B; Lv Y; Wang X; Liu G; Wang P
    Pathol Res Pract; 2022 Sep; 237():154020. PubMed ID: 35868058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNX5 suppresses clear cell renal cell carcinoma progression by inducing CD44 internalization and epithelial-to-mesenchymal transition.
    Zhou Q; Li J; Ge C; Chen J; Tian W; Tian H
    Mol Ther Oncolytics; 2022 Mar; 24():87-100. PubMed ID: 35024436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MITD1 Deficiency Suppresses Clear Cell Renal Cell Carcinoma Growth and Migration by Inducing Ferroptosis through the TAZ/SLC7A11 Pathway.
    Zhang Y; Li Y; Qiu Q; Chen Z; Du Y; Liu X
    Oxid Med Cell Longev; 2022; 2022():7560569. PubMed ID: 36046690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNFAIP8 promotes the migration of clear cell renal cell carcinoma by regulating the EMT.
    Zhong M; Zhu M; Liu Y; Lin Y; Wang L; Ye Y; Chen H; Yang Y; Zhuang G; Huang J
    J Cancer; 2020; 11(10):3061-3071. PubMed ID: 32226521
    [No Abstract]   [Full Text] [Related]  

  • 15. Upregulation of Metallothionein 1 G (MT1G) Negatively Regulates Ferroptosis in Clear Cell Renal Cell Carcinoma by Reducing Glutathione Consumption.
    Zhang W; Luo M; Xiong B; Liu X
    J Oncol; 2022; 2022():4000617. PubMed ID: 36204178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
    Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
    J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of RUNX3: Upregulation of E-cadherin and downregulation of the epithelial-mesenchymal transition in clear-cell renal cell carcinoma.
    Yang RN; Zhou FR; Wang HY; Wang QH; Ji JL; Huang T; Guo C; Dong Z; Cao YW
    Open Life Sci; 2022; 17(1):1579-1590. PubMed ID: 36518886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The induction of ferroptosis by KLF11/NCOA4 axis: the inhibitory role in clear cell renal cell carcinoma.
    Zhou ZQ; Lv X; Liu SB; Qu HC; Xie QP; Sun LF; Li G
    Hum Cell; 2023 Nov; 36(6):2162-2178. PubMed ID: 37642832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RCAN1.4 acts as a suppressor of cancer progression and sunitinib resistance in clear cell renal cell carcinoma.
    Song Z; Cao Q; Ruan H; Yang H; Wang K; Bao L; Cheng G; Xu T; Xiao H; Wang C; Liu D; Chen K; Zhang X
    Exp Cell Res; 2018 Nov; 372(2):118-128. PubMed ID: 30267660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.